4.7 Article

Fetal exposure to HIV-1 alters chemokine receptor expression by CD4+T cells and increases susceptibility to HIV-1

期刊

SCIENTIFIC REPORTS
卷 4, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/srep06690

关键词

-

资金

  1. NWO AGIKO-Stipendium [92003417]
  2. Dutch AIDS Foundation [2006015]

向作者/读者索取更多资源

Absolute numbers of lymphocytes are decreased in uninfected infants born to HIV-1-infected women (HIV-1-exposed). Although the exact mechanism is unknown, fetal exposure to maternal HIV-1-infection could prime the immune system and affect T cell trafficking. We compared the expression of chemokine receptors on cord blood CD4(+) T cells from HIV-1-exposed children and healthy controls. At baseline CD4(+) T cells had a largely naive phenotype. However, stimulation with cytokines resulted in an upregulation of inflammatory response-related chemokine receptors on CD4(+) T cells, with HIV-1-exposed infants having a significantly higher frequency of CD4(+) T cells expressing, in particularly T(h)2 associated chemokine receptors (CCR3 p < 0.01, CCR8 p = 0.03). Numbers of naive CCR7(+) CD4(+) T cells were reduced (p = 0.01) in HIV-1-exposed infants. We further assessed whether the inflammatory phenotype was associated with susceptibility to HIV-1 and detected higher levels of p24 upon in in vitro infection of stimulated CD4(+) T cells of HIV-1-exposed infants. In summary, fetal exposure to HIV-1 primes the immune system in the infant leading to an enhanced immune activation and altered T cell homing, with potential ramifications regarding T cell responses and the acquisition of HIV-1 as an infant.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

SARS-CoV-2 infection activates dendritic cells via cytosolic receptors rather than extracellular TLRs

Lieve E. H. van der Donk, Julia Eder, John L. van Hamme, Philip J. M. Brouwer, Mitch Brinkkemper, Ad C. van Nuenen, Marit J. van Gils, Rogier W. Sanders, Neeltje A. Kootstra, Marta Bermejo-Jambrina, Teunis B. H. Geijtenbeek

Summary: This study suggests that SARS-CoV-2 does not directly activate TLR4, but instead utilizes intracellular viral sensors for sensing and infecting host cells. This finding may explain the lack of efficient immune response to SARS-CoV-2 early during infection.

EUROPEAN JOURNAL OF IMMUNOLOGY (2022)

Article Gastroenterology & Hepatology

Quantified integrated hepatitis B virus is related to viral activity in patients with chronic hepatitis B

Robin Erken, Vladimir Loukachov, Karel Dort, Anne den Hurk, R. Bart Takkenberg, Anniki Niet, Louis Jansen, Sophie Willemse, Henk Reesink, Neeltje Kootstra

Summary: Integrated HBV levels are closely related to clinical outcomes in patients with chronic hepatitis B and can be quantified. Integrated HBV levels are correlated with surrogate markers for virological activity, but not with cccDNA levels, and can predict HBsAg loss.

HEPATOLOGY (2022)

Article Immunology

Telomere Length Declines in Persons With Human Immunodeficiency Virus Before Antiretroviral Therapy Start but Not After Viral Suppression: A Longitudinal Study Over >17 Years

Isabella C. Schoepf, Christian W. Thorball, Bruno Ledergerber, Neeltje A. Kootstra, Peter Reiss, Marieke Raffenberg, Tanja Engel, Dominique L. Braun, Barbara Hasse, Christine Thurnheer, Catia Marzolini, Marco Seneghini, Enos Bernasconi, Matthias Cavassini, Helene Buvelot, Jose R. Arribas, Roger D. Kouyos, Jacques Fellay, Huldrych F. Gunthard, Philip E. Tarr

Summary: The study found that there was a significant decline in telomere length during untreated chronic HIV infection, but no significant change during suppressive antiretroviral therapy.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Immunology

Similar Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Similar Nucleocapsid Antibody Levels in People With Well-Controlled Human Immunodeficiency Virus (HIV) and a Comparable Cohort of People Without HIV

Myrthe L. Verburgh, Anders Boyd, Ferdinand W. N. M. Wit, Maarten F. Schim van der Loeff, Marc van der Valk, Margreet Bakker, Neeltje A. Kootstra, Lia van der Hoek, Peter Reiss

Summary: In the Amsterdam-based AGE(h)IV Cohort Study, researchers prospectively compared the incidence and risk factors for SARS-CoV-2 infection between HIV-positive and HIV-negative participants. They found that HIV-positive individuals with suppressed viremia and adequate CD4 cell counts had similar risk of SARS-CoV-2 acquisition and similar post-infection nucleocapsid antibody levels compared to a comparable HIV-negative cohort.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Neurosciences

Correlation between cerebrospinal fluid and plasma neurofilament light protein in treated HIV infection: results from the COBRA study

Jasmini Alagaratnam, Davide De Francesco, Henrik Zetterberg, Amanda Heslegrave, Jamie Toombs, Neeltje A. Kootstra, Jonathan Underwood, Magnus Gisslen, Peter Reiss, Sarah Fidler, Caroline A. Sabin, Alan Winston

Summary: In PWH on suppressive antiretroviral treatment, there is a moderate correlation between CSF and plasma NfL, similar to lifestyle-similar HIV-negative individuals. Consideration of renal function and bodyweight may be required when utilizing plasma NfL.

JOURNAL OF NEUROVIROLOGY (2022)

Article Medicine, General & Internal

Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming

Roos S. G. Sablerolles, Wim J. R. Rietdijk, Abraham Goorhuis, Douwe F. Postma, Leo G. Visser, Daryl Geers, Katharina S. Schmitz, Hannah M. Garcia Garrido, Marion P. G. Koopmans, Virgil A. S. H. Dalm, Neeltje A. Kootstra, Anke L. W. Huckriede, Melvin Lafeber, Debbie van Baarle, Corine H. GeurtsvanKessel, Rory D. de Vries, P. Hugo M. van der Kuy

Summary: This study investigated the immunogenicity and reactogenicity of a homologous or heterologous booster in healthcare workers who had received a single-shot Ad26.COV2.S vaccine. The results showed that booster vaccinations increased the levels of S-specific binding antibodies, neutralizing antibodies, and T-cell responses compared to a single Ad26.COV2.S vaccination. Boosters containing mRNA-based vaccines induced significantly higher levels of binding antibodies than homologous boosters. The mRNA-1273 booster was the most immunogenic but had higher reactogenicity compared to the BNT162b2 and Ad26.COV2.S boosters. Local and systemic reactions were generally mild to moderate in the first 2 days after booster administration.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Hematology

Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients

Sabine Haggenburg, Birgit Lissenberg-Witte, Rob S. van Binnendijk, Gerco den Hartog, Michel S. Bhoekhan, Nienke J. E. Haverkate, Dennis M. de Rooij, Johan van Meerloo, Jacqueline Cloos, Neeltje A. Kootstra, Dorine Wouters, Suzanne S. Weijers, Ester M. M. van Leeuwen, Hetty J. Bontkes, Saida Tonouh-Aajoud, Mirjam H. M. Heemskerk, Rogier W. Sanders, Elianne Roelandse-Koop, Quincy Hofsink, Kazimierz Groen, Lucia Cetinel, Louis Schellekens, Yvonne M. den Hartog, Belle Toussaint, Iris M. J. Kant, Thecla Graas, Emma de Pater, Willem A. Dik, Marije D. Engel, Cheyenne R. N. Pierie, Suzanne R. Janssen, Edith van Dijkman, Meliawati Poniman, Judith A. Burger, Joey H. Bouhuijs, Gaby Smits, Nynke Y. Rots, Sonja Zweegman, Arnon P. Kater, Tom van Meerten, Pim G. N. J. Mutsaers, Jaap A. van Doesum, Annoek E. C. Broers, Marit J. van Gils, Abraham Goorhuis, Caroline E. Rutten, Mette D. Hazenberg, Inger S. Nijhof

Summary: Vaccination guidelines for hematological patients are typically conservative. However, this study shows that most patients, even those with compromised immune systems, can develop sufficient antibody concentrations after receiving the Moderna vaccine. However, certain treatments may affect the vaccine's efficacy.

BLOOD ADVANCES (2022)

Article Gastroenterology & Hepatology

A Prospective Five-Year Follow-up After peg-Interferon Plus Nucleotide Analogue Treatment or no Treatment in HBeAg Negative Chronic Hepatitis B Patients

Robin Erken, Vladimir V. Loukachov, Annikki de Niet, Louis Jansen, Femke Stelma, Jeltje T. Helder, Martine W. Peters, Hans L. Zaaijer, Neeltje A. Kootstra, Sophie B. Willemse, Hendrik W. Reesink

Summary: In this study, long-term follow-up of patients with chronic hepatitis B was conducted, and it was found that combination treatment did not influence the disappearance of HBsAg, while low baseline HBsAg levels could predict HBsAg loss.

JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2022)

Letter Gastroenterology & Hepatology

Untitled Reply

Vladimir V. Loukachov, Karel A. van Dort, Robin Erken, Henk W. Reesink, Neeltje A. Kootstra

HEPATOLOGY (2022)

Article Immunology

Durability of Immune Responses After Boosting in Ad26.COV2.S-Primed Healthcare Workers

Roos S. G. Sablerolles, Wim J. R. Rietdijk, Abraham Goorhuis, Douwe F. Postma, Leo G. Visser, Katharina S. Schmitz, Daryl Geers, Susanne Bogers, Eva van Haren, Marion P. G. Koopmans, Virgil A. S. H. Dalm, Neeltje A. Kootstra, Anke L. W. Huckriede, Renate Akkerman, Martin Beukema, Melvin Lafeber, Debbie van Baarle, Rory D. de Vries, P. Hugo M. van der Kuy, Corine H. GeurtsvanKessel

Summary: This study found that SARS-CoV-2-specific binding antibodies, neutralizing antibodies, and T cells remained detectable 5 months after boosting with Ad26.COV2.S vaccine, although there was a decline in antibody levels and limited cross-reactivity with Omicron BA.1.

CLINICAL INFECTIOUS DISEASES (2023)

Article Biochemistry & Molecular Biology

Vaginal bacterium Prevotella timonensis turns protective Langerhans cells into HIV-1 reservoirs for virus dissemination

Nienke H. van Teijlingen, Leanne C. Helgers, Ramin Sarrami-Forooshani, Esther M. Zijlstra-Willems, John L. van Hamme, Celia Segui-Perez, Marleen Y. van Smoorenburg, Hanneke Borgdorff, Janneke H. H. M. van de Wijgert, Elisabeth van Leeuwen, Joris Am van der Post, Karin Strijbis, Carla M. S. Ribeiro, Teunis B. H. Geijtenbeek

Summary: Dysbiosis of vaginal microbiota is associated with increased HIV-1 acquisition. Prevotella timonensis induces uptake and transmission of HIV-1 by vaginal Langerhans cells, enhancing infection susceptibility, thus advocating targeted treatment of P. timonensis to limit HIV-1 infection.

EMBO JOURNAL (2022)

Letter Gastroenterology & Hepatology

Reply

Vladimir Loukachov, Karel van Dort, Robin Erken, Henk W. Reesink, Neeltje Kootstra

HEPATOLOGY (2023)

Meeting Abstract Hematology

Sickle Cell Disease Patients Mount Adequate Humoral but Reduced Cellular Responses to COVID-19 Vaccination

Cilia R. Pothast, Quincy Hofsink, Sabine Haggenburg, Michel Bhoekhan, Nienke J. E. Haverkate, Romy C. Dijkland, Kayleigh van Dijk, Frederik J. H. Falkenburg, Annoek E. C. Broers, Jaap van Doesum, Robert S. van Binnendijk, Gerco den Hartog, Judith A. Burger, Joey H. Bouhuijs, Birgit Lissenberg-Witte, Gaby P. Smits, Dorine Wouters, Ester M. M. van Leeuwen, Hetty J. Bontkes, Neeltje A. Kootstra, Sonja Zweegman, Arnon P. Kater, Kaz Groen, Tom van Meerten, Pim G. N. J. Mutsaers, Tim Beaumont, Marit J. van Gils, Abraham Goorhuis, Mette D. Hazenberg, Inger S. Nijhof, Mirjam H. M. Heemskerk, Caroline E. Rutten

Article Immunology

Leukocyte Count and Coronary Artery Disease Events in People With Human Immunodeficiency Virus: A Longitudinal Study

Emma F. Avery, Julia N. Kleynhans, Bruno Ledergerber, Isabella C. Schoepf, Christian W. Thorball, Neeltje A. Kootstra, Peter Reiss, Lene Ryom, Dominique L. Braun, Maria C. Thurnheer, Catia Marzolini, Marco Seneghini, Enos Bernasconi, Matthias Cavassini, Helene Buvelot, Roger D. Kouyos, Jacques Fellay, Huldrych F. Guenthard, Philip E. Tarr

Summary: In Switzerland, leukocyte count is independently associated with coronary artery disease (CAD) events in people with HIV (PWH), even after adjusting for traditional and HIV-related risk factors.

CLINICAL INFECTIOUS DISEASES (2023)

Correction Immunology

Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions (vol 13, 893648, 2022)

Angela I. Schriek, Marlies M. van Haaren, Meliawati Poniman, Gillian Dekkers, Arthur E. H. Bentlage, Marloes Grobben, Gestur Vidarsson, Rogier W. Sanders, Theo Verrips, Teunis B. H. Geijtenbeek, Raimond Heukers, Neeltje A. Kootstra, Steven W. de Taeye, Marit J. van Gils

FRONTIERS IN IMMUNOLOGY (2022)

暂无数据